BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 40 filers reported holding BICYCLE THERAPEUTICS PLC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $237,895 | -71.5% | 8,037 | -77.6% | 0.00% | -100.0% |
Q3 2022 | $834,000 | +48.7% | 35,857 | +7.3% | 0.00% | 0.0% |
Q2 2022 | $561,000 | -97.6% | 33,412 | -93.9% | 0.00% | -95.8% |
Q1 2022 | $23,515,000 | -32.1% | 551,415 | -3.0% | 0.02% | -25.0% |
Q4 2021 | $34,608,000 | +441.3% | 568,568 | +269.9% | 0.03% | +433.3% |
Q3 2021 | $6,393,000 | +23.6% | 153,723 | -9.8% | 0.01% | +20.0% |
Q2 2021 | $5,172,000 | -3.8% | 170,375 | -5.3% | 0.01% | -16.7% |
Q1 2021 | $5,376,000 | +77.0% | 179,992 | +6.3% | 0.01% | +100.0% |
Q4 2020 | $3,038,000 | +5.1% | 169,250 | +11.5% | 0.00% | -25.0% |
Q3 2020 | $2,890,000 | -10.6% | 151,730 | -26.9% | 0.00% | 0.0% |
Q2 2020 | $3,232,000 | -49.7% | 207,583 | -52.8% | 0.00% | -20.0% |
Q1 2020 | $6,426,000 | +402.8% | 439,468 | +224.3% | 0.01% | +150.0% |
Q4 2019 | $1,278,000 | -19.6% | 135,496 | -2.9% | 0.00% | 0.0% |
Q3 2019 | $1,589,000 | +13.3% | 139,496 | 0.0% | 0.00% | -33.3% |
Q2 2019 | $1,403,000 | – | 139,496 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,915,274 | $57,209,000 | 21.43% |
Atlas Venture Advisors, Inc. | 612,696 | $18,301,000 | 3.38% |
Logos Global Management LP | 800,000 | $23,896,000 | 2.33% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,957,961 | $58,484,000 | 1.28% |
Ghost Tree Capital, LLC | 150,000 | $4,481,000 | 1.05% |
Parkman Healthcare Partners LLC | 75,454 | $2,254,000 | 0.52% |
MOODY ALDRICH PARTNERS LLC | 74,060 | $2,212,000 | 0.32% |
Point72 Asset Management, L.P. | 1,577,493 | $47,120,000 | 0.22% |
Eventide Asset Management | 411,838 | $12,302,000 | 0.18% |
SAMLYN CAPITAL, LLC | 437,728 | $13,076,000 | 0.18% |